A subscription to JoVE is required to view this content. Sign in or start your free trial.
Here, we present a sensitive and specific method to detect oncogene-induced transcription-replication conflicts (TRCs) using the proximity ligation assay (PLA). This approach leverages specific antibodies targeting PCNA and phospho-CTD RNAPII, enabling the assessment of TRC prevalence between RNA polymerase II transcription and DNA replication machinery.
Both DNA replication and RNA transcription utilize genomic DNA as their template, necessitating spatial and temporal separation of these processes. Conflicts between the replication and transcription machinery, termed transcription-replication conflicts (TRCs), pose a considerable risk to genome stability, a critical factor in cancer development. While several factors regulating these collisions have been identified, pinpointing primary causes remains difficult due to limited tools for direct visualization and clear interpretation. In this study, we directly visualize TRCs using a proximity ligation assay (PLA), leveraging antibodies specific to PCNA and phosphorylated CTD of RNA polymerase II. This approach allows precise measurement of TRCs between replication and transcription processes mediated by RNA polymerase II. The method is further enhanced through DNA primers conjugated covalently to these antibodies, coupled with PCR amplification using fluorescent probes, providing a highly sensitive and specific means of detecting endogenous TRCs. Fluorescence microscopy enables the visualization of these conflicts, offering a powerful tool to study genome instability mechanisms associated with cancer. This technique addresses the gap in direct TRC visualization, allowing for a more comprehensive analysis and understanding of the underlying processes driving genome instability in cells.
The genome serves as a template for essential biological processes, including replication and transcription. In healthy cells, RNA transcription and DNA replication machinery typically cooperate and are spatially and temporally segregated1,2,3,4. However, under pathological conditions, such as oncogene overexpression, this harmonious cooperation can be disrupted.
Oncogenes often drive elevated transcription levels, increasing the likelihood of collisions between the transcription and replication machinery
1. Lentivirus production and transduction into target cell line
γH2AX serves as a biomarker for DNA damage. Overexpression of KRAS (G12D) impairs genomic stability in these cells, as evidenced by the increased γH2AX signal in Western blot analysis (Figure 2A). Additionally, the intensified S9.6 dot blot signal in KRAS (G12D)-expressing cells compared to vector controls (Figure 2B) indicates that oncogenic KRAS expression leads to the accumulation of aberrant R-loops, which may contribute to DNA break formation.
.......The RNAPII transcription machinery can create a hindrance to DNA replication fork progression26,27, promoting TRCs and DNA damage, especially in cancer cells28,29. Deciphering the proteins that regulate TRCs and understanding the detailed mechanisms can help us comprehend how these harmful events occur and guide the development of new therapeutic approaches in the future. Therefore, to fully understand TR.......
This work was supported by the University of South China's startup funding.
....Name | Company | Catalog Number | Comments |
Clarity Western ECL Substrate | Bio-Rad | 1705061 | |
Duolink In Situ Detection Reagents Green | Sigma | DUO92014 | |
FLAG antibody | Millipore | F7425 | |
gamma H2AX antibody | Cell Signaling | 25955 | |
Glycogen, molecular biology grade | ThermoFisher | R0561 | |
Image J | NIH | https://imagej.net/ij/ | |
nitrocellulose membranes | Amersham | 10600004 | |
PCNA antibody | Cell Signaling | 13110 | |
pLVX-Kras G12D | N/A | N/A | |
pMD2.G | Addgene | 12259 | |
Proteinase K, recombinant, PCR grade | ThermoFisher | EO0491 | |
psPAX2 | Addgene | 12260 | |
RNAPII antibody | SCBT | sc-56767 | |
S9.6 antibody | Active motif | 65683 | |
UV crosslinkers | Fisher Scientific | FB-UVXL-1000 |
Explore More Articles
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2025 MyJoVE Corporation. All rights reserved